New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children

Pınar Yavuz; Osman Oguz Demir; Yasemin Ozsurekci; Seza Ozen; Banu Anlar; Goknur Haliloglu

doi:10.1016/j.jpeds.2022.02.046

New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children

J Pediatr. 2022 Jun:245:213-216. doi: 10.1016/j.jpeds.2022.02.046. Epub 2022 Feb 26.

Authors

Pınar Yavuz¹, Osman Oguz Demir², Yasemin Ozsurekci³, Seza Ozen⁴, Banu Anlar¹, Goknur Haliloglu⁵

Affiliations

¹ Division of Pediatric Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
² Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
³ Division of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
⁴ Division of Pediatric Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
⁵ Division of Pediatric Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Electronic address: gtuncer@hacettepe.edu.tr.

Abstract

Neurologic complications have been associated with multisystem inflammatory syndrome in children, possibly involving autoimmune mechanisms. Here, we report a 6-year-old girl who developed myasthenia 11 weeks after severe acute respiratory syndrome coronavirus 2 infection and 8 weeks after the onset of severe multisystem inflammatory syndrome in children.

Keywords: COVID-19; MIS-C; myasthenia; new-onset.

Publication types

Case Reports

MeSH terms

COVID-19* / complications
Child
Female
Humans
Systemic Inflammatory Response Syndrome

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related